| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kisiday John David | Chief Science Officer | 3321 COLLEGE AVENUE, SUITE 246, DAVIE | /s/ David John Kisiday | 06 Feb 2026 | 0002109789 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | ZEOX | Common Stock, $0.001 par value | 50,000 | 23 Jan 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares of restricted common stock granted to the Reporting Person on January 23, 2026 under the Issuer's 2021 Equity Incentive Plan (the "Incentive Plan"). The shares vest as to 20,000 shares on the first anniversary of the Reporting Person's employment agreement with the Issuer effective January 23, 2026 (the "Employment Agreement") and 30,000 shares on the second anniversary of the Employment Agreement, subject to the Reporting Person's continued service with the Issuer and the other terms and conditions of the Incentive Plan. |